We are live on
!
Find out more
OCA
OpenArc Corporate Advisory Portfolio holdings
AUM
$8.41B
This Fund
S&P 500
This Quarter
Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
(+20%)
Cap. Flow
+$539M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6
quarters
Top 10 Avg Time Held
1.6
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.82% |
| 2 | Technology | 16.24% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Healthcare | 3.98% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Merck
MRK
$359B
| $5.52M | 0.07% |
42,950
-11,348
| -21% | -$1.33M |
2025 Q4
2 quarters
|
|
152
Natera
NTRA
$57.3B
| $5.29M | 0.06% |
19,490
+2,564
| +15% | +$547K |
2025 Q4
2 quarters
|
|
153
Oracle
ORCL
$416B
| $5.27M | 0.06% |
35,960
+1,066
| +3% | +$193K |
2025 Q4
2 quarters
|
|
154
AstraZeneca
AZN
$246B
| $5.26M | 0.06% |
27,729
+1,078
| +4% | +$203K |
2025 Q4
2 quarters
|
|
155
iShares Core S&P US Value ETF
IUSV
$27.7B
| $4.98M | 0.06% |
45,179
-4,353
| -9% | -$471K |
2025 Q4
2 quarters
|
|
156
Martin Marietta Materials
MLM
$33.9B
| $4.89M | 0.06% |
8,486
-5,048
| -37% | -$2.99M |
2025 Q4
2 quarters
|
|
157
Allstate
ALL
$58.8B
| $4.89M | 0.06% |
20,556
-148
| -0.7% | -$32.2K |
2025 Q4
2 quarters
|
|
158
Acuity Brands
AYI
$8.87B
| $4.83M | 0.06% |
12,823
-3,160
| -20% | -$937K |
2025 Q4
2 quarters
|
|
159
Qualcomm
QCOM
$186B
| $4.8M | 0.06% |
25,975
+5,641
| +28% | +$1.05M |
2025 Q4
2 quarters
|
|
160
General Dynamics
GD
$90.8B
| $4.71M | 0.06% |
13,293
+282
| +2% | +$96.6K |
2025 Q4
2 quarters
|
|
161
iShares Russell 2000 ETF
IWM
$78.3B
| $4.67M | 0.06% |
15,552
+1,483
| +11% | +$417K |
2025 Q4
2 quarters
|
|
162
Vanguard Russell 1000 Growth ETF
VONG
$47.8B
| $4.64M | 0.06% |
36,291
+69
| +0.2% | +$8.56K |
2025 Q4
2 quarters
|
|
163
Bank of New York Mellon
BNY
$96.9B
| $4.57M | 0.05% |
31,584
+946
| +3% | +$129K |
2025 Q4
2 quarters
|
|
164
First Trust NASDAQ-100 Technology Index Fund
QTEC
$3.98B
| $4.57M | 0.05% |
+13,644
| New | +$3.91M |
2026 Q2
0 quarters
|
|
165
Berkshire Hathaway Class A
BRK.A
$1.11T
| $4.49M | 0.05% |
6
| – | – |
2025 Q4
2 quarters
|
|
166
Paychex
PAYX
$37.2B
| $4.49M | 0.05% |
45,612
+655
| +1% | +$62K |
2025 Q4
2 quarters
|
|
167
iShares Core MSCI International Developed Markets ETF
IDEV
$32.9B
| $4.46M | 0.05% |
50,154
+947
| +2% | +$83.9K |
2025 Q4
2 quarters
|
|
168
iShares US Industrials ETF
IYJ
$2.02B
| $4.4M | 0.05% |
26,381
+6,830
| +35% | +$1.08M |
2025 Q4
2 quarters
|
|
169
Schwab US Broad Market ETF
SCHB
$45.3B
| $4.38M | 0.05% |
+151,368
| New | +$4.24M |
2026 Q2
0 quarters
|
|
170
iShares Core US Aggregate Bond ETF
AGG
$137B
| $4.37M | 0.05% |
44,174
-13,189
| -23% | -$1.3M |
2025 Q4
2 quarters
|
|
171
Ross Stores
ROST
$72.1B
| $4.37M | 0.05% |
20,541
-770
| -4% | -$173K |
2025 Q4
2 quarters
|
|
172
Aon
AON
$58.3B
| $4.3M | 0.05% |
+12,976
| New | +$4.19M |
2026 Q2
0 quarters
|
|
173
Williams Companies
WMB
$90.7B
| $4.29M | 0.05% |
57,692
-937
| -2% | -$69K |
2025 Q4
2 quarters
|
|
174
Applied Materials
AMAT
$395B
| $4.25M | 0.05% |
5,882
+961
| +20% | +$443K |
2025 Q4
2 quarters
|
|
175
EQT Corp
EQT
$33.3B
| $4.16M | 0.05% |
78,311
-35,207
| -31% | -$1.98M |
2025 Q4
2 quarters
|
|
Similar funds
HCM
MWM
DKCM
IGAM
FLPIM
MAM
AIM
SBH
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.